nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cautionary tale: Is this APOB whole-gene duplication actually pathogenic?
|
Lazarte, Julieta |
|
|
14 |
5 |
p. 631-635 |
artikel |
2 |
Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity
|
Levine, Jordan A. |
|
|
14 |
5 |
p. 667-674 |
artikel |
3 |
Bempedoic acid: A new player in lipid-lowering therapies
|
Cuevas, Ada |
|
|
14 |
5 |
p. 615-616 |
artikel |
4 |
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials
|
Bays, Harold E. |
|
|
14 |
5 |
p. 649-659.e6 |
artikel |
5 |
Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346
|
Defesche, Joep C. |
|
|
14 |
5 |
p. 742 |
artikel |
6 |
“Corrigendum to Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study” Journal of Clinical Lipidology Volume 12, Issue 3, May–June 2018, Pages 718-727.e6
|
Harris, William S. |
|
|
14 |
5 |
p. 740 |
artikel |
7 |
Corrigendum to PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study Volume 14, Issue 3, May–June 2020, Pages 322-330.e5
|
Daniels, Stephen |
|
|
14 |
5 |
p. 741 |
artikel |
8 |
Editorial Board
|
|
|
|
14 |
5 |
p. A1-A4 |
artikel |
9 |
Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia
|
Mohebi, Reza |
|
|
14 |
5 |
p. 636-638 |
artikel |
10 |
From the editor: Connectedness and lipidology
|
Guyton, John R. |
|
|
14 |
5 |
p. 611 |
artikel |
11 |
From the President of the International Atherosclerosis Society
|
Santos, Raul D. |
|
|
14 |
5 |
p. 613-614 |
artikel |
12 |
Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort
|
Brandt, Eric J. |
|
|
14 |
5 |
p. 695-706.e4 |
artikel |
13 |
Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
|
Tanner, Rikki M. |
|
|
14 |
5 |
p. 720-729 |
artikel |
14 |
Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis
|
McComb, Mason |
|
|
14 |
5 |
p. 675-684.e2 |
artikel |
15 |
News from the NLA
|
|
|
|
14 |
5 |
p. 612 |
artikel |
16 |
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial
|
Roth, Eli M. |
|
|
14 |
5 |
p. 707-719 |
artikel |
17 |
Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis
|
Yamatani, Kotoko |
|
|
14 |
5 |
p. 730-739 |
artikel |
18 |
Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia
|
Vuorio, Alpo |
|
|
14 |
5 |
p. 617-618 |
artikel |
19 |
Successful pharmacological management of a child with compound heterozygous familial hypercholesterolemia and review of the recent literature
|
Sreedharan, Aravind Venkatesh |
|
|
14 |
5 |
p. 639-645 |
artikel |
20 |
Successful treatment of a patient with mitochondrial myopathy with alirocumab
|
Cicero, Arrigo F.G. |
|
|
14 |
5 |
p. 646-648 |
artikel |
21 |
Table of Contents
|
|
|
|
14 |
5 |
p. A5-A7 |
artikel |
22 |
The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia
|
Paquette, Martine |
|
|
14 |
5 |
p. 660-666 |
artikel |
23 |
Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study
|
Nasr, Alexis |
|
|
14 |
5 |
p. 685-694.e2 |
artikel |
24 |
Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability
|
Nidorf, Stefan Mark |
|
|
14 |
5 |
p. 619-630 |
artikel |